As of 2026-04-07, the Relative Valuation of Solid Biosciences Inc (SLDB) is (35.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.74 USD, the upside of Solid Biosciences Inc based on Relative Valuation is -558.0%.
The range of the Relative Valuation is (32.45) - (36.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 22.5x | 20.4x |
| Forward P/E multiples | 18.1x - 21.3x | 20.9x |
| Fair Price | (32.45) - (36.50) | (35.45) |
| Upside | -519.2% - -571.5% | -558.0% |
| Date | P/E |
| 2026-04-06 | -4.51 |
| 2026-04-02 | -4.36 |
| 2026-04-01 | -4.30 |
| 2026-03-31 | -4.19 |
| 2026-03-30 | -3.78 |
| 2026-03-27 | -4.14 |
| 2026-03-26 | -4.50 |
| 2026-03-25 | -4.21 |
| 2026-03-24 | -3.89 |
| 2026-03-23 | -4.16 |
| 2026-03-20 | -4.09 |
| 2026-03-19 | -4.15 |
| 2026-03-18 | -4.15 |
| 2026-03-17 | -4.52 |
| 2026-03-16 | -4.36 |
| 2026-03-13 | -4.26 |
| 2026-03-12 | -4.49 |
| 2026-03-11 | -4.49 |
| 2026-03-10 | -4.76 |
| 2026-03-09 | -4.67 |
| 2026-03-06 | -3.93 |
| 2026-03-05 | -3.27 |
| 2026-03-04 | -3.58 |
| 2026-03-03 | -3.47 |
| 2026-03-02 | -3.61 |
| 2026-02-27 | -3.62 |
| 2026-02-26 | -3.66 |
| 2026-02-25 | -3.68 |
| 2026-02-24 | -3.60 |
| 2026-02-23 | -3.42 |
| 2026-02-20 | -3.33 |
| 2026-02-19 | -3.43 |
| 2026-02-18 | -3.45 |
| 2026-02-17 | -3.20 |
| 2026-02-13 | -3.61 |
| 2026-02-12 | -3.54 |
| 2026-02-11 | -3.73 |
| 2026-02-10 | -4.04 |
| 2026-02-09 | -4.00 |
| 2026-02-06 | -3.80 |
| 2026-02-05 | -3.63 |
| 2026-02-04 | -3.80 |
| 2026-02-03 | -3.81 |
| 2026-02-02 | -3.75 |
| 2026-01-30 | -3.76 |
| 2026-01-29 | -3.84 |
| 2026-01-28 | -3.82 |
| 2026-01-27 | -3.83 |
| 2026-01-26 | -3.76 |
| 2026-01-23 | -3.84 |